| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| | Plasmodium falciparum (isolate 3D7) Erythrocyte membrane- |
| | associated antigen (a.a.61-460) |
| | Swiss-Prot #: | Q8IC35 |
| | Entry name: | Q8IC35_PLAF7 |
| | Protein | Erythrocyte membrane-associated antigen |
| | Gene names: | MAL7P1.12 |
| | Organism: | Plasmodium falciparum (isolate 3D7) |
| | Codon-optimized cDNA Clone |
| | Cat#: | RPL-0439 |
| | Description: | Applications:1. Codon-optimized cDNA sequence designed for recombinant |
| | protein production in both E.coli and Mammalian cell. The cDNA has been |
| | cloned into E.coli expression vector with 6x Histidine tag. 2. May be used as |
| | RNAi assistance to restore the loss-of-function. |
| | Tag: | A 6x histidine tag |
| | Formulation: | Liquid |
| | Storage: | -20° to -70° C. Avoid repeated freeze-thaw cycles. |
| | Recombinant Protein |
| | Cat#: | PL-0439 |
| | Source: | Recombinant protein derived from E.coli. Or Yeast |
| | Tag: | A 6x histidine tag |
| | Formulation: | Liquid |
| | Purity: | > 90%, as determined by SDS-PAGE under reducing conditions |
| | Activity: | N/A |
| | Applications: | Western Blot, may be used for other applications determined by |
| | Storage: | -20° to -70° C. Avoid repeated freeze-thaw cycles. |
| | Sequence: | | MFLRNFSYTL ITYRYMYIFS LINILKTTSV IIKTRHKLNH INNSRGIKSL NINSNNLFFF LRSKIRKTQN YILNNNINKK |
| | NYNALFYKLN NKEKKMNNKF SKSLNMNNST NKNDHLMNDN IASFNKNTDI KNPRSFNQNR NITYSKQFSQ NNNYSSTHNN |
| | NSVSKGKASG SYINSGNVNV SSNQYVNSNN NIILIVIILI VVVIIIIIII VVIIINREMN KNNEGPNSSF NETKLNNSSN |
| | FHINNKEKKN YNNILSNNNN NNINNKNNDG DNINMLHINE NSGMYGTKSN YNNKDYLLIS NNMKDKNMYL NNNTLTNTNN |
| | LDNSLKINNY NNKHNDKNIN TRSSKILEDP NSYNNALKNN DSRYNYYNEN FTNNIKNVNN ANTGVNSLKN MKNPFNMNKK |
| | YMSHYNNNDN NNNNNNNNNN NNNNNNNNNN NNSHNNNYNN QPHSNNYYYN NKSNDNLNNN KTSSSSYAPN FKRETSDDIS |
| | NNNINYNNTN YNNTNYNNTN YNNNNYNKIK DSNNNSNNNM IIMTNEMNSI DLHKNINILT MESSNCNKID MNNNILSTNE |
| | TIHNVGNKHG NNDINKTNHH NNTTTTSSSS SNNNMLKLNN IMKNKDINKN DNIESNHQYN AHDILYDNSR GAMVDTMTPG |
| | YNRSSRSNKL SMQNYNHINH NMDSSKNMIS PNDRSSINKG DITMNNNENN NNNNNMGISR SSSNMFTKHN SFHNNNNNDL |
| | NQINNFGIKK NEYYGNFSTS ANAKNVNNLI NKIEDNKNNN NINNNGGHLD LDSDAFCYYD FNEFLNYMYK DENILTLFYI |
| | RKNYLKAESK EEFINENDKI KYSIIWSFTN DEKIVVYGTH NTKKLSKKVC VKKILLKLKN ISLLELDQMT KWMINSLNVI |
| | LKVENKNLEN KFNNNVYSCN IEWKINNKLY QASAQHEHEK IAELVATQRL YMILYDVKEQ LIRENDFSKM SDDNKRFINS |
| | YDNTTIINNN TSNNNNNNNI NNTGSNNNTL YNKYMSSNSK NFDDGNMLNQ NKFNKNQGAN KNFNELMYNN NNHTASSNNN |
| | NNNNVLSYQE NKNIKYGDAS NDHMLNRNNN MNMNNYMNNV CYNNNNNMNN ILTSATDIHH NNNNVNNMNN MNNMNNMNNM |
| | NNMNNMNNMN NMNNMNNVNK NVGHMGATQG TIMNNNMFLN ANNAKYMNEN MNLLNNAQHG GIQQVGAQQI GAQPIGIQEV |
| | GTQPEQVADP NDLIEYCLTK QDASSIQMLR NNIASRYKIQ QSEVFEQVFN LYKCTLDWEW KNGKNTCKAK SVGYGSTKSL |
| | AKCEAAYDML VKNNLIEYIS STDRKNAQFI RDLISKDLNK ALNMAIQFIM QYSSNAWSIF VVYLLRELLI DGNYDPINRL |
| | LNTIVEVSRE GRMEVEKMEK DMNQNVNNVN HINNMNNLNN MNNLNNMNNL NNVNDESINT ASATMFHNNK VDENNDNNNN |
| | NSSQFFNPYI QNKNLTDNNY VHKLVSIELW EKLIDECVVI LNDKLCFNCI SLLQQVELDY SIFISKCAHD YYKKYRIMLA |
| | LELQANLAQS IQEKKNFEYL HENKSLLLKL KSITMPVLSC TCTLTNEEKE WMKSTQMRED DIVLLKPCDT LLKDEDAWSN |
| | SLIGSITSTK SDNTVYNINI RIFSAENTKK ANVKYNKYRL YLLLNIVTHE RMLQALRSIT FISSIPTQYQ SPYVFTPEIR |
| | FLLLHSYNKY SKYIAQNGKL NEEIANYEKI KMDFQNNESL KNNTMSDDIL NDYSKEAKNP YEDLLNESIN KQIGNSQVED |
| | IDKYLIESIN LPTNLPLNDS QKLACLSALT RRLTLVQGPP GTGKTHVACA IIDSWHKQNS NKKILAVADS NVAANNLVEG |
| | LKKRNIQAVR VGAGSDSDFH EEAIMEFHRY KDLLKLRKNN MQKEAKVMKA LLFLEAVKKY NVVIATCVGS GHEIFDNEKF |
| | ERVIIDECAQ SIEPSNLIPL GHYCNNLVLI GDHKQLPPTI ISPDAIKLGL DKSLLERFVM AKIAPVHLLN TQRRMHLSIC |
| | VFPNFHFYDN KLKTANVTEE NRPIIKGFLW PNPKCRLAFI DVSIGKPGSK FENAYGTSKF NLYEIEPLIT VLKSIINEGC |
| | For pricing and availability Click Here >>> |
| | Recombinant-Protein-cDNA-membrane-antigen-Plasmodium-falciparum |
| | FOR in vitro RESEARCH USE ONLY. NOT FOR USE IN HUMANS. |
|
| ||||||||||||||||||||||||||||||||||
| |||||
| For cDNA or Recombinant Protein Search (Input Cat#, Gene name, Protein Name, Accession Number |
|
Copyright Bioclone Inc All rights Reserved